Is able to inhibit the growth of Mycobacterium tuberculosis (MIC=0.22-3.52 uM against strain H37Rv and 2 multidrug-resistant strains) (PubMed:30791616). May also show neurotoxic activity (Probable). Expressed by the venom duct. The cysteine framework is XXIX (CCC-C-CC-C-C). May contain 4 disulfide bonds. Is a potential drug lead for the treatment of tuberculosis. Belongs to the conotoxin O1 superfamily.